What is the sipra membership?

Could you qualify for the Medicare GLP-1 Bridge?

Jillian Foglesong Stabile, MD

FAAFP, DABOM · Reviewed July 18, 2026 · CMS program rules, verified July 2026

Question 1 of 7

Do you have Medicare drug coverage (Part D)? This includes a standalone Part D plan, a Medicare Advantage plan with drug coverage, or a Special Needs Plan.

Educational self-screen only, based on published Medicare program rules as of July 2026. Not an application, an approval, a diagnosis, or a guarantee of coverage. Final eligibility is confirmed by your provider's prior authorization and by Medicare, and program rules can change. Confirm details at Medicare.gov/glp1bridge or 1-800-MEDICARE. Individual results vary.

Chapter 01 · The program

What the Medicare GLP-1 Bridge is

The Medicare GLP-1 Bridge is a time-limited federal program that runs from July 1, 2026 through December 31, 2027. It lets eligible Medicare beneficiaries pay a flat $50 per monthly supply of a covered GLP-1 medication used for weight management. This matters because traditional Medicare drug plans generally do not cover GLP-1 medications for weight loss at all, so without the Bridge most people would pay the full cash price.

One point clears up a common misconception: the Bridge is available nationwide, in every state and US territory, and Medicare drug plans do not opt in. It runs outside the normal Part D benefit through a single central processor. So the only coverage question is whether you have Medicare drug coverage at all, not whether your specific plan or state participates.

Chapter 02 · Who qualifies

The eligibility criteria

To qualify, you generally need Medicare drug coverage (Part D), you must be 18 or older, and the GLP-1 must be prescribed for weight management along with lifestyle changes, not for a condition Medicare already covers. Then one of three BMI tiers applies: a BMI of 35 or higher on its own, a BMI of 30 to 34.9 plus at least one qualifying condition, or a BMI of 27 to 29.9 plus at least one of a shorter list of qualifying conditions.

Three uses are handled by your regular Part D plan instead of the Bridge: type 2 diabetes, moderate to severe sleep apnea, and fatty liver disease (MASH). That is not a denial of care; it means the prescription should go through your plan, because those are already covered indications. There is also a rule for people already receiving a plan-covered GLP-1 in 2026, who continue through their existing plan.

Chapter 03 · Next steps

How eligibility is actually confirmed

This tool is a self-screen, not an application. There is no self-enrollment and no automatic enrollment. Your provider drives it: they send a prescription for a covered GLP-1 and, when asked, submit a prior authorization certifying that you meet the criteria. Medicare's processor then confirms coverage and you receive a letter. You can also self-screen at Medicare.gov/glp1bridge or call 1-800-MEDICARE. A result here of you may qualify means it is worth a conversation with your provider, never that you are approved.

Every medication on sipra is prescribed by a licensed physician, so your care always starts with a visit. Your sipra membership gives you ongoing access to those physician visits, so you can check in, adjust your plan, and ask questions whenever you need, without paying per visit. It is how we keep high-quality care convenient: one membership, physician access whenever you need it, and support at every step.

Sources

Centers for Medicare and Medicaid Services. "Medicare GLP-1 Bridge." Program overview, authority, dates, and $50 monthly copay. Accessed July 2026. cms.gov
Centers for Medicare and Medicaid Services. "Medicare GLP-1 Bridge: Information for Part D Plans." Full clinical criteria, BMI tiers, excluded conditions, and covered medications. Accessed July 2026. cms.gov
Medicare.gov. "Medicare GLP-1 Bridge" beneficiary eligibility and how to confirm coverage. Accessed July 2026. medicare.gov

Compounded medications are not FDA-approved and require a patient-specific prescription. Brand names are trademarks of their owners; sipra is not affiliated with them.

General education, not medical advice. Last reviewed July 18, 2026 by Jillian Foglesong Stabile, MD, FAAFP, DABOM. Prices snapshot CMS program rules, verified July 2026. Individual results vary.